A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73

Genes and Development

Volumn 19, Issue 3, 2005, Pages 316-321

  Asher, Gad ^a   Tsvetkov, Peter ^a   Kahana, Chaim ^a   Shaul, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

20S proteasome; NADH; NQO1; p53; p73; Protein degradation

Indexed keywords

20S PROTEASOME; DICOUMAROL; PROTEIN P53; PROTEIN P73; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE QUINONE OXIDOREDUCTASE 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING ASSAY; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; IONIZING RADIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; UBIQUITINATION; WESTERN BLOTTING;

ANIMALS; COENZYMES; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN;

ANIMALIA; PYRONIA TITHONUS;

EID: 13244275245     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.319905     Document Type: Article

References (23)

1. Anwar, A., Dehn, D., Siegel, D., Kepa, J.K., Tang, L.J., Pietenpol, J.A., and Ross, D. 2003. Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J. Biol. Chem. 278: 10368-10373.
2. Asher, G., Lotem, J., Cohen, B., Sachs, L., and Shaul, Y. 2001. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc. Natl. Acad. Sci. 98: 1188-1193.
3. Asher, G., Lotem, J., Kama, R., Sachs, L., and Shaul, Y. 2002a. NQO1 stabilizes p53 through a distinct pathway. Proc. Natl. Acad. Sci. 99: 3099-3104.
4. Asher, G., Lotem, J., Sachs, L., Kahana, C., and Shaul, Y. 2002b. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc. Natl. Acad. Sci. 99: 13125-13130.
5. Asher, G., Lotem, J., Tsvetkov, P., Reiss, V., Sachs, L., and Shaul, Y. 2003. P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1. Proc. Natl. Acad. Sci. 100: 15065-15070.
6. Asher, G., Lotem, J., Sachs, L., and Shaul, Y. 2004. p53-dependent apoptosis and NAD(P)H:quinone oxidoreductase 1. Methods Enzymol. 382: 278-293.
7. Chowdary, D.R., Dermody, J.J., Jha, K.K., and Ozer, H.L. 1994. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell. Biol. 14: 1997-2003.
8. Coux, O., Tanaka, K., and Goldberg, A.L. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65: 801-847.
9. Friguet, B., Bulteau, A.L., Conconi, M., and Petropoulos, I. 2002. Redox control of 20S proteasome. Methods Enzymol. 353: 253-262.
10. Glickman, M.H., Rubin, D.M., Coux, O., Wefes, I., Pfeifer, G., Cjeka, Z., Baumeister, W., Fried, V.A., and Finley, D. 1998. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94: 615-623.
11. Goldberg, A.L. 2003. Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-899.
12. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299.
13. Hershko, A. 1996. Lessons from the discovery of the ubiquitin system. Trends Biochem. Sci. 21: 445-449.
14. Hershko, A. and Ciechanover, A. 1998. The ubiquitin system. Annu. Rev. Biochem. 67: 425-479.
15. Hosoda, S., Nakamura, W., and Hayashi, K. 1974. Properties and reaction mechanism of DT diaphorase from rat liver. J. Biol. Chem. 249: 6416-6423.
16. Kubbutat, M.H., Jones, S.N., and Vousden, K.H. 1997. Regulation of p53 stability by Mdm2. Nature 387: 299-303.
17. Long II, D.J., Gaikwad, A., Multani, A., Pathak, S., Montgomery, C.A., Gonzalez, F.J., and Jaiswal, A.K. 2002. Disruption of the NAD(P)H-:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia. Cancer Res. 62: 3030-3036.
18. Ma, Q., Cui, K., Xiao, F., Lu, A.Y., and Yang, C.S. 1992. Identification of a glycine-rich sequence as an NAD(P)H-binding site and tyrosine 128 as a dicumarol-binding site in rat liver NAD(P)H:quinone oxidoreductase by site-directed mutagenesis. J. Biol. Chem. 267: 22298-22304.
19. Mamroud-Kidron, E., Omer-Itsicovich, M., Bercovich, Z., Tobias, K.E., Rom, E., and Kahana, C. 1994. A unified pathway for the degradation of ornithine decarboxylase in reticulocyte lysate requires interaction with the polyamine-induced protein, ornithine decarboxylase anti-zyme. Eur. J. Biochem. 226: 547-554.
20. Pickart, C.M. and Cohen, R.E. 2004. Proteasomes and their kin: Proteases in the machine age. Nat. Rev. Mol. Cell. Biol. 5: 177-187.
21. Verma, R. and Deshaies, R.J. 2000. A proteasome howdunit: The case of the missing signal. Cell 101: 341-344.
22. Vogelstein, B., Lane, D., and Levine, A.J. 2000. Surfing the p53 network. Nature 408: 307-310.
23. Zhang, F., Su, K., Yang, X., Bowe, D.B., Paterson, A.J., and Kudlow, J.E. 2003. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115: 715-725.